Страница 1+ · 50 сайта
| NCT01020890 | Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms | COMPLETED | — | AstraZeneca | Gastroesophageal Reflux Disease | Research Site | Yambol | Ямбол |
| NCT01076764 | Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy | COMPLETED | PHASE3 | Sanofi | Acute Coronary Syndrome | Investigational Site Number 100506 | Yambol | Ямбол |
| NCT01583218 | Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) | COMPLETED | PHASE3 | Portola Pharmaceuticals | Venous Thromboembolism (VTE) | — | Yambol | Ямбол |
| NCT01671007 | GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States) | COMPLETED | — | Boehringer Ingelheim | Stroke; Atrial Fibrillation | Specialized Hosp.f.Active Treatment, Cardiology Dept, Yambol | Yambol | Ямбол |
| NCT01730534 | Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events | COMPLETED | PHASE3 | AstraZeneca | Diabetes Mellitus, Non-Insulin-Dependent; High Risk for Cardiovascular Event | Research Site | Yambol | Ямбол |
| NCT01928771 | Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma | COMPLETED | PHASE3 | AstraZeneca | Asthma | Research Site | Yambol | Ямбол |
| NCT01991795 | A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | AstraZeneca | Diabetes Mellitus, Type 2 | Research Site | Yambol | Ямбол |
| NCT01994720 | [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] | COMPLETED | PHASE3 | AstraZeneca | Acute Ischaemic Stroke; Transient Ischaemic Attack | Research Site | Yambol | Ямбол |
| NCT02108262 | A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction. | COMPLETED | PHASE2 | CSL Behring | Acute Myocardial Infarction | Study Site 12007 | Yambol | Ямбол |
| NCT02155660 | Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History | COMPLETED | PHASE3 | AstraZeneca | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | Research Site | Yambol | Ямбол |
| NCT02161757 | A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma | COMPLETED | PHASE3 | AstraZeneca | Uncontrolled Asthma | Research Site | Yambol | Ямбол |
| NCT02164864 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | COMPLETED | PHASE3 | Boehringer Ingelheim | Atrial Fibrillation; Percutaneous Coronary Intervention | Specialized Hosp.f.Active Treatment, Cardiology Dept, Yambol | Yambol | Ямбол |
| NCT02174627 | Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis | COMPLETED | PHASE3 | AstraZeneca | Anemia | Research Site | Yambol | Ямбол |
| NCT02174731 | Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis. | COMPLETED | PHASE3 | AstraZeneca | Anemia | Research Site | Yambol | Ямбол |
| NCT02224157 | A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma | COMPLETED | PHASE3 | AstraZeneca | Asthma | Research Site | Yambol | Ямбол |
| NCT02258542 | A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA | COMPLETED | PHASE3 | AstraZeneca | Asthma | Research Site | Yambol | Ямбол |
| NCT02278341 | Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis | COMPLETED | PHASE3 | Astellas Pharma Europe B.V. | Anemia; End Stage Renal Disease (ESRD) | Site BG35937 | Yambol | Ямбол |
| NCT02504216 | Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities | COMPLETED | PHASE3 | Bayer | Peripheral Artery Disease | — | Yambol | Ямбол |
| NCT02540993 | Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease | COMPLETED | PHASE3 | Bayer | Chronic Kidney Disease | — | Yambol | Ямбол |
| NCT02545049 | Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease | COMPLETED | PHASE3 | Bayer | Diabetic Kidney Disease | — | Yambol | Ямбол |
| NCT02993406 | Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo | COMPLETED | PHASE3 | Esperion Therapeutics, Inc. | Cardiovascular Diseases; Statin Adverse Reaction | — | Yambol | Ямбол |
| NCT03071692 | Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) | TERMINATED | PHASE3 | Kowa Research Institute, Inc. | Type2 Diabetes; Dyslipidemia | MHAT "Sv. Panteleymon", AD | Yambol | Ямбол |
| NCT03496298 | Effect of Efpeglenatide on Cardiovascular Outcomes | TERMINATED | PHASE3 | Sanofi | Type 2 Diabetes Mellitus | Investigational Site Number 1000016 | Yambol | Ямбол |
| NCT03710291 | Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis | TERMINATED | PHASE3 | Tricida, Inc. | Metabolic Acidosis; Chronic Kidney Disease | Investigative Site 1203 | Yambol | Ямбол |
| NCT03989232 | A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes | COMPLETED | PHASE3 | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | Novo Nordisk Investigational Site | Yambol | Ямбол |
| NCT04020341 | A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) | COMPLETED | PHASE3 | GlaxoSmithKline | Urinary Tract Infections | GSK Investigational Site | Yambol | Ямбол |
| NCT04123405 | Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis | COMPLETED | PHASE3 | Sandoz | Rhinosinusitis | Sandoz Investigative Site | Yambol | Ямбол |
| NCT04233424 | D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection | COMPLETED | PHASE3 | PolyPid Ltd. | Surgical Site Infection; Colon Surgery; Abdominal Surgery; Post-Op Infection | "Multiprofile Hospital for Active Treatment "Sveti Panteleymon"-Yambol AD | Yambol | Ямбол |
| NCT04435626 | Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% | COMPLETED | PHASE3 | Bayer | Heart Failure | Multiprofile Hospital for Active Treatment Sveti Panteleymon Yambol | Cardiology Department | Yambol | Ямбол |
| NCT04534439 | Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy | COMPLETED | PHASE2 | Aptabio Therapeutics, Inc. | Diabetic Nephropathies; Diabetes Mellitus, Type 2; Nephropathy, Diabetic | Sveti Panteleymon Yambol | Yambol | Ямбол |
| NCT04688931 | A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer | TERMINATED | PHASE3 | UroGen Pharma Ltd. | Bladder Cancer; Urothelial Carcinoma; Urothelial Carcinoma Bladder | Multiprofile Hospital for Active Treatment "Sveti Pantaleymon", Yambol, Department of Urology | Yambol | Ямбол |
| NCT04707469 | Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes | COMPLETED | PHASE3 | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | MHAT Sveti Panteleimon - Yambol AD | Yambol | Ямбол |
| NCT04760626 | A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before | COMPLETED | PHASE3 | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | MHAT Sveti Panteleimon - Yambol AD | Yambol | Ямбол |
| NCT04795726 | A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR) | COMPLETED | — | Bayer | Diabetic Retinopathy | MHAT Sveti Pantaleymon - Yambol | Yambol | Ямбол |
| NCT04847232 | Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes) | TERMINATED | PHASE3 | AstraZeneca | Hyperkalemia | Research Site | Yambol | Ямбол |
| NCT04957719 | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION | PHASE3 | Viatris Innovation GmbH | Acute Myocardial Infarction | MHAT "Sv. Panteleymon" - Yambol, AD | Yambol | Ямбол |
| NCT04957719 | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION | PHASE3 | Viatris Innovation GmbH | Acute Myocardial Infarction | The Heart Specialists Clinic and Diagnostic Center | Yambol | Ямбол |
| NCT05013008 | An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants | COMPLETED | PHASE2 | Bayer | Chronic Kidney Disease; Type 2 Diabetes Mellitus | MHAT Sveti Pantaleymon - Yambol | Yambol | Ямбол |
| NCT05021835 | ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation | COMPLETED | PHASE3 | Novo Nordisk A/S | Cardiovascular Risk; Chronic Kidney Disease; Inflammation | MC Berbatov EOOD, Cherni Drin | Yambol | Ямбол |
| NCT05056727 | A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia | TERMINATED | PHASE3 | AstraZeneca | Renal Insufficiency, Chronic; Hyperkalemia | Research Site | Yambol | Ямбол |
| NCT05144984 | A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes | COMPLETED | PHASE2 | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | MC Berbatov EOOD, Cherni Drin | Yambol | Ямбол |
| NCT05243550 | A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | UroGen Pharma Ltd. | Bladder Cancer; Urothelial Carcinoma; Urothelial Carcinoma Bladder | Multiprofile Hospital for Active Treatment "Sveti Pantaleymon", Yambol, Department of Urology | Yambol | Ямбол |
| NCT05350202 | Emp-Activity: Empagliflozin Functional Capacity | COMPLETED | — | Boehringer Ingelheim | Heart Failure | Dr. Petrova | Yambol | Ямбол |
| NCT05350202 | Emp-Activity: Empagliflozin Functional Capacity | COMPLETED | — | Boehringer Ingelheim | Heart Failure | Dr. Toneva-Zhelaeva | Yambol | Ямбол |
| NCT05567796 | A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight | ACTIVE_NOT_RECRUITING | PHASE3 | Novo Nordisk A/S | Obesity | MC Berbatov EOOD, Cherni Drin | Yambol | Ямбол |
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight | COMPLETED | PHASE3 | Novo Nordisk A/S | Obesity; Diabetes Mellitus, Type 2 | MHAT Sveti Panteleimon - Yambol AD | Yambol | Ямбол |
| NCT05669755 | REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels | ACTIVE_NOT_RECRUITING | PHASE3 | Novo Nordisk A/S | Cardiovascular Disease | MHAT Sveti Panteleimon - Yambol AD | Yambol | Ямбол |
| NCT05669755 | REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels | ACTIVE_NOT_RECRUITING | PHASE3 | Novo Nordisk A/S | Cardiovascular Disease | Medical centre Runkovi OOD | Yambol | Ямбол |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 | Janssen Research & Development, LLC | Atrial Fibrillation | MHAT Sv. Panteleymon AD | Yambol | Ямбол |
| NCT06040086 | Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations | COMPLETED | PHASE3 | AstraZeneca | Chronic Obstructive Pulmonary Disease (COPD) | Research Site | Yambol | Ямбол |
NCT01020890
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms
COMPLETEDYambol · Ямбол
Gastroesophageal Reflux Disease
Спонсор: AstraZeneca
Research Site
NCT01076764
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
COMPLETEDPHASE3Yambol · Ямбол
Acute Coronary Syndrome
Спонсор: Sanofi
Investigational Site Number 100506
NCT01583218
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
COMPLETEDPHASE3Yambol · Ямбол
Venous Thromboembolism (VTE)
Спонсор: Portola Pharmaceuticals
NCT01671007
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
COMPLETEDYambol · Ямбол
Stroke; Atrial Fibrillation
Спонсор: Boehringer Ingelheim
Specialized Hosp.f.Active Treatment, Cardiology Dept, Yambol
NCT01730534
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
COMPLETEDPHASE3Yambol · Ямбол
Diabetes Mellitus, Non-Insulin-Dependent; High Risk for Cardiovascular Event
Спонсор: AstraZeneca
Research Site
NCT01928771
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
COMPLETEDPHASE3Yambol · Ямбол
Asthma
Спонсор: AstraZeneca
Research Site
NCT01991795
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
COMPLETEDPHASE3Yambol · Ямбол
Diabetes Mellitus, Type 2
Спонсор: AstraZeneca
Research Site
NCT01994720
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
COMPLETEDPHASE3Yambol · Ямбол
Acute Ischaemic Stroke; Transient Ischaemic Attack
Спонсор: AstraZeneca
Research Site
NCT02108262
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
COMPLETEDPHASE2Yambol · Ямбол
Acute Myocardial Infarction
Спонсор: CSL Behring
Study Site 12007
NCT02155660
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
COMPLETEDPHASE3Yambol · Ямбол
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Спонсор: AstraZeneca
Research Site
NCT02161757
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
COMPLETEDPHASE3Yambol · Ямбол
Uncontrolled Asthma
Спонсор: AstraZeneca
Research Site
NCT02164864
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
COMPLETEDPHASE3Yambol · Ямбол
Atrial Fibrillation; Percutaneous Coronary Intervention
Спонсор: Boehringer Ingelheim
Specialized Hosp.f.Active Treatment, Cardiology Dept, Yambol
NCT02174627
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
COMPLETEDPHASE3Yambol · Ямбол
Anemia
Спонсор: AstraZeneca
Research Site
NCT02174731
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.
COMPLETEDPHASE3Yambol · Ямбол
Anemia
Спонсор: AstraZeneca
Research Site
NCT02224157
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
COMPLETEDPHASE3Yambol · Ямбол
Asthma
Спонсор: AstraZeneca
Research Site
NCT02258542
A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA
COMPLETEDPHASE3Yambol · Ямбол
Asthma
Спонсор: AstraZeneca
Research Site
NCT02278341
Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
COMPLETEDPHASE3Yambol · Ямбол
Anemia; End Stage Renal Disease (ESRD)
Спонсор: Astellas Pharma Europe B.V.
Site BG35937
NCT02504216
Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
COMPLETEDPHASE3Yambol · Ямбол
Peripheral Artery Disease
Спонсор: Bayer
NCT02540993
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
COMPLETEDPHASE3Yambol · Ямбол
Chronic Kidney Disease
Спонсор: Bayer
NCT02545049
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
COMPLETEDPHASE3Yambol · Ямбол
Diabetic Kidney Disease
Спонсор: Bayer
NCT02993406
Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
COMPLETEDPHASE3Yambol · Ямбол
Cardiovascular Diseases; Statin Adverse Reaction
Спонсор: Esperion Therapeutics, Inc.
NCT03071692
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
TERMINATEDPHASE3Yambol · Ямбол
Type2 Diabetes; Dyslipidemia
Спонсор: Kowa Research Institute, Inc.
MHAT "Sv. Panteleymon", AD
NCT03496298
Effect of Efpeglenatide on Cardiovascular Outcomes
TERMINATEDPHASE3Yambol · Ямбол
Type 2 Diabetes Mellitus
Спонсор: Sanofi
Investigational Site Number 1000016
NCT03710291
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
TERMINATEDPHASE3Yambol · Ямбол
Metabolic Acidosis; Chronic Kidney Disease
Спонсор: Tricida, Inc.
Investigative Site 1203
NCT03989232
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
COMPLETEDPHASE3Yambol · Ямбол
Diabetes Mellitus, Type 2
Спонсор: Novo Nordisk A/S
Novo Nordisk Investigational Site
NCT04020341
A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
COMPLETEDPHASE3Yambol · Ямбол
Urinary Tract Infections
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT04123405
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis
COMPLETEDPHASE3Yambol · Ямбол
Rhinosinusitis
Спонсор: Sandoz
Sandoz Investigative Site
NCT04233424
D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
COMPLETEDPHASE3Yambol · Ямбол
Surgical Site Infection; Colon Surgery; Abdominal Surgery; Post-Op Infection
Спонсор: PolyPid Ltd.
"Multiprofile Hospital for Active Treatment "Sveti Panteleymon"-Yambol AD
NCT04435626
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
COMPLETEDPHASE3Yambol · Ямбол
Heart Failure
Спонсор: Bayer
Multiprofile Hospital for Active Treatment Sveti Panteleymon Yambol | Cardiology Department
NCT04534439
Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
COMPLETEDPHASE2Yambol · Ямбол
Diabetic Nephropathies; Diabetes Mellitus, Type 2; Nephropathy, Diabetic
Спонсор: Aptabio Therapeutics, Inc.
Sveti Panteleymon Yambol
NCT04688931
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
TERMINATEDPHASE3Yambol · Ямбол
Bladder Cancer; Urothelial Carcinoma; Urothelial Carcinoma Bladder
Спонсор: UroGen Pharma Ltd.
Multiprofile Hospital for Active Treatment "Sveti Pantaleymon", Yambol, Department of Urology
NCT04707469
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
COMPLETEDPHASE3Yambol · Ямбол
Diabetes Mellitus, Type 2
Спонсор: Novo Nordisk A/S
MHAT Sveti Panteleimon - Yambol AD
NCT04760626
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
COMPLETEDPHASE3Yambol · Ямбол
Diabetes Mellitus, Type 2
Спонсор: Novo Nordisk A/S
MHAT Sveti Panteleimon - Yambol AD
NCT04795726
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)
COMPLETEDYambol · Ямбол
Diabetic Retinopathy
Спонсор: Bayer
MHAT Sveti Pantaleymon - Yambol
NCT04847232
Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
TERMINATEDPHASE3Yambol · Ямбол
Hyperkalemia
Спонсор: AstraZeneca
Research Site
NCT04957719
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
ENROLLING_BY_INVITATIONPHASE3Yambol · Ямбол
Acute Myocardial Infarction
Спонсор: Viatris Innovation GmbH
MHAT "Sv. Panteleymon" - Yambol, AD
NCT04957719
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
ENROLLING_BY_INVITATIONPHASE3Yambol · Ямбол
Acute Myocardial Infarction
Спонсор: Viatris Innovation GmbH
The Heart Specialists Clinic and Diagnostic Center
NCT05013008
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants
COMPLETEDPHASE2Yambol · Ямбол
Chronic Kidney Disease; Type 2 Diabetes Mellitus
Спонсор: Bayer
MHAT Sveti Pantaleymon - Yambol
NCT05021835
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
COMPLETEDPHASE3Yambol · Ямбол
Cardiovascular Risk; Chronic Kidney Disease; Inflammation
Спонсор: Novo Nordisk A/S
MC Berbatov EOOD, Cherni Drin
NCT05056727
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
TERMINATEDPHASE3Yambol · Ямбол
Renal Insufficiency, Chronic; Hyperkalemia
Спонсор: AstraZeneca
Research Site
NCT05144984
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
COMPLETEDPHASE2Yambol · Ямбол
Diabetes Mellitus, Type 2
Спонсор: Novo Nordisk A/S
MC Berbatov EOOD, Cherni Drin
NCT05243550
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
ACTIVE_NOT_RECRUITINGPHASE3Yambol · Ямбол
Bladder Cancer; Urothelial Carcinoma; Urothelial Carcinoma Bladder
Спонсор: UroGen Pharma Ltd.
Multiprofile Hospital for Active Treatment "Sveti Pantaleymon", Yambol, Department of Urology
NCT05350202
Emp-Activity: Empagliflozin Functional Capacity
COMPLETEDYambol · Ямбол
Heart Failure
Спонсор: Boehringer Ingelheim
Dr. Petrova
NCT05350202
Emp-Activity: Empagliflozin Functional Capacity
COMPLETEDYambol · Ямбол
Heart Failure
Спонсор: Boehringer Ingelheim
Dr. Toneva-Zhelaeva
NCT05567796
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
ACTIVE_NOT_RECRUITINGPHASE3Yambol · Ямбол
Obesity
Спонсор: Novo Nordisk A/S
MC Berbatov EOOD, Cherni Drin
NCT05649137
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
COMPLETEDPHASE3Yambol · Ямбол
Obesity; Diabetes Mellitus, Type 2
Спонсор: Novo Nordisk A/S
MHAT Sveti Panteleimon - Yambol AD
NCT05669755
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
ACTIVE_NOT_RECRUITINGPHASE3Yambol · Ямбол
Cardiovascular Disease
Спонсор: Novo Nordisk A/S
MHAT Sveti Panteleimon - Yambol AD
NCT05669755
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
ACTIVE_NOT_RECRUITINGPHASE3Yambol · Ямбол
Cardiovascular Disease
Спонсор: Novo Nordisk A/S
Medical centre Runkovi OOD
NCT05757869
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
ACTIVE_NOT_RECRUITINGPHASE3Yambol · Ямбол
Atrial Fibrillation
Спонсор: Janssen Research & Development, LLC
MHAT Sv. Panteleymon AD
NCT06040086
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
COMPLETEDPHASE3Yambol · Ямбол
Chronic Obstructive Pulmonary Disease (COPD)
Спонсор: AstraZeneca
Research Site
Страница 1+